Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04784234 · ClinicalTrials.gov registry record · NA

Vision Preservation and Restoration Following a 6 Month Trial of GlaucoCetin

A NA study, sponsored by Wills Eye.

Terminated
Registry status
NA
Development phase
12
Enrollment target

NCT04784234 is a NA study that was terminated before completion, run by Wills Eye. The registered enrollment target is 12 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04784234, a NA study, was terminated before completion, sponsored by Wills Eye.

TERMINATED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

This study is looking at changes in vision and visual function before and after a six month trial of a daily medical food called GlaucoCetin, formulated with ingredients to support and protect the optic nerve cells. Open angle glaucoma patients will be randomized to receive either a placebo or the medical food for 6 months. We hope to learn if this medical food can improve the vision of our glaucoma patients and to report the findings obtained to the general public.

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT GlaucoCetin

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2021-02-01
Est. Completion 2022-10-27
Phase NA

Sponsor

Wills Eye

59 total trials

What the Registry Record Tells You About NCT04784234

The ClinicalTrials.gov registry entry for NCT04784234 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wills Eye, which has 59 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT04784234 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04784234 about?

NCT04784234 is a clinical study titled "Vision Preservation and Restoration Following a 6 Month Trial of GlaucoCetin". This study is looking at changes in vision and visual function before and after a six month trial of a daily medical food called GlaucoCetin, formulated with ingredients to support and protect the optic nerve cells. Open angle glaucoma patients will be randomized to receive either a placebo or the m...

What is the current status of trial NCT04784234?

This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2021-02-01. Estimated completion is 2022-10-27.

What interventions are being tested in trial NCT04784234?

The interventions under investigation include: Placebo (OTHER), GlaucoCetin (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04784234?

This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.